Skip to main content

Published locations for EASD: SGLT2 inhibitors show potential in 1DM despite DKA concern

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. EASD: SGLT2 inhibitors show potential in 1DM despite DKA concern

User login

  • Reset your password
  • /content/easd-sglt2-inhibitors-show-potential-1dm-despite-dka-concern
  • /familypracticenews/article/103026/diabetes/easd-sglt2-inhibitors-show-potential-1dm-despite-dka
  • /internalmedicinenews/article/103026/diabetes/easd-sglt2-inhibitors-show-potential-1dm-despite-dka
  • /clinicalendocrinologynews/article/103026/diabetes/easd-sglt2-inhibitors-show-potential-1dm-despite
  • /endocrinology/article/103026/diabetes/easd-sglt2-inhibitors-show-potential-1dm-despite-dka-concern
  • /internalmedicine/article/103026/diabetes/easd-sglt2-inhibitors-show-potential-1dm-despite-dka
  • /familymedicine/article/103026/diabetes/easd-sglt2-inhibitors-show-potential-1dm-despite-dka-concern
  • /type-2-diabetes-icymi/article/103026/diabetes/easd-sglt2-inhibitors-show-potential-1dm-despite-dka